Jiangsu Hengrui Pharmaceuticals
¥47.20Change from previous close: +3.46%Absolute change: +¥1.58
Valuation
Data as of October 3, 2026
Valuation multiples
- Market cap
- ¥313.28B
- Enterprise value
- ¥313.44B
- P/E (trailing 12 months)
- 40.7
- Forward P/E
- 30.7
- PEG
- 0.93
- Price/book
- 5.03
- Price/sales
- 9.62
- EV/EBITDA
- 33.2
- EV/revenue
- 9.63
Profitability and growth
- Gross margin
- 86.3%
- Operating margin
- 31.6%
- Net margin
- 24.9%
- ROE
- 14.5%
- ROA
- 8.8%
- Revenue growth (year over year)
- 13.0%
- Earnings growth (year over year)
- 13.3%
Financial health
- Total cash
- ¥40.64B
- Total debt
- ¥67.47M
- Debt/equity
- 0.00
- Current ratio
- 9.23
- Quick ratio
- 8.36
Dividends
- Annual dividend per share
- ¥0.20
- Dividend yield
- 0.4%
- Payout ratio
- 16.4%
- Ex-dividend date
- May 27, 2026
Analysts and estimates
- Average price target
- ¥70.92
- Median price target
- ¥70.00
- High price target
- ¥111.00
- Low price target
- ¥50.00
- Analysts with a price target
- 17
- Consensus
- Strong buy
- Forward EPS
- ¥1.54
- EPS estimate, current year
- ¥1.37
Shares and trading
- Beta
- 0.04
- Average volume
- 84.35M
- Shares outstanding
- 6.38B
- Float
- 3.77B
- Institutional ownership
- 14.0%
- Insider ownership
- 46.3%